Servier signs €1bn-plus AI pact with Iktos
In its second AI-focused drug discovery deal in the space of a week, Servier has announced a €1bn partnership with France's Iktos.
Court blocks HHS' 340B rebate programme pilot
Hospitals that challenged a US pilot of a new rebate model for medicines provided to low-income people have won another legal victory.
Study finds weight returns more quickly in GLP-1 users
People who use drugs like GLP-1 agonists to lose weight regain it more quickly than those who use a conventional approach of diet and exercise.
Hengrui gets first OK for a PD-L1/TGF-beta drug for cancer
Hengrui has achieved a milestone in oncology as retlirafusp alfa is approved in China, its first world market, for gastric cancer.
OpenAI launches ChatGPT Health portal
OpenAI unveils ChatGPT Health, which will link queries to medical records and health and wellness apps – if users are happy to share the data.
Oncology
Patients
R&D
Partner Content
5th mRNA-Based Therapeutics Summit Europe
The Summit is the leading European industry-focused forum dedicated to accelerating the development of messenger RNA (mRNA) medicines
VuuAI and Amiculum partner to transform content engagement i...
Amiculum, a global health communications agency, has entered into an exciting strategic collaboration with VuuAI, a GenAI-driven content production automation plat
10th Tumor Models Summit San Francisco
Join the West Coast's premier pharma and biotech gathering, the 10th Tumor Models Summit San Francisco, where innovation meets opportunity
The PM Society Careers Event – 18th February 2026
Join us for our popular event to see how your skills and interests could add value to this vital and constantly evolving industry.
Frontiers Health Turns 10
Celebrating a Decade of Innovation and Collaboration in Berlin, November 11–12, 2025 Berlin / November 7th, 2025 | Marking its 10th anniversary,